Drug,Drug Mechanism,Target Gene(s),Drug Constrained Regulon Activity,Drug Constrained Program Activity,All Regulon(s),Overactive Regulon(s),Underactive Regulon(s),All Program(s),Overactive Program(s),Underactive Program(s),Regulon Activity Summary,Program Activity Summary,Mutations,Regulators,MINER Target Type,max_glioblastoma.multiforme_phase,Other FDA Appr.,TargetMutatedInPatient,MutatedInPatient,TargetType,MutatedDetail,Drug Action,Molecule Type,Target Class,Toxicity Class,MEDDRA Code,CHEMBL_ID,Reactome,GO,Hallmarks
CARMUSTINE,RNA inhibitor:DNA inhibitor:Glutathione reductase inhibitor,GSR,1,1,"1663,2320,2679,41,644,681,707","1663,2320,2679,41,644,681,707",NA,101,101,NA,O: 7 U: 0 A: 7,O: 1 U: 0 A: 1,,,Regulon_Gene,4,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR:INHIBITOR:INHIBITOR,Small molecule,Enzyme,,,CHEMBL513,NA:NA:NA:NA:NA,GO_STRESS_GRANULE_ASSEMBLY:GO_REGULATION_OF_CIRCADIAN_RHYTHM:NA:NA:NA,
BEVACIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,0.8260869565217391,1,"1074,1119,1221,1226,1330,1339,1444,1709,1774,2060,2738,2782,2946,2956,3089,3220,3424,42,491,543,646,752,818","1074,1119,1221,1226,1330,1444,1709,2060,2738,2782,2956,3089,3220,42,491,543,646,752,818",NA,"35,44,169","35,44,169",NA,O: 19 U: 0 A: 23,O: 3 U: 0 A: 3,,,Regulon_Gene,4,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Antibody,Secreted protein,,,CHEMBL1201583,"Metabolism of carbohydrates:Glycogen synthesis:Plasma lipoprotein assembly, remodeling, and clearance:Other semaphorin interactions:NA",GO_MULTI_MULTICELLULAR_ORGANISM_PROCESS:GO_RESPONSE_TO_OXYGEN_LEVELS:GO_UROGENITAL_SYSTEM_DEVELOPMENT:GO_NEPHRON_DEVELOPMENT:GO_NEURON_PROJECTION_GUIDANCE,HALLMARK_HYPOXIA:HALLMARK_MTORC1_SIGNALING:HALLMARK_TNFA_SIGNALING_VIA_NFKB
HYDROXYUREA,Ribonucleoside-diphosphate reductase RR1 inhibitor,RRM2,0.9230769230769231,0,"1030,1720,1818,2051,2292,2529,3637,366,3676,501,693,906,964","1030,1720,1818,2051,2292,3637,366,3676,501,693,906,964",NA,153,NA,NA,O: 12 U: 0 A: 13,O: 0 U: 0 A: 1,,,Regulon_Gene,3,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,Carcinogenicity:Hematological toxicity,10029104.0:10005329.0,CHEMBL467,Cellular Senescence:Oxidative Stress Induced Senescence:RNA Polymerase I Promoter Opening:DNA methylation:Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,GO_NUCLEOSOME_ASSEMBLY:GO_NUCLEOSOME_ORGANIZATION:GO_CHROMATIN_ASSEMBLY_OR_DISASSEMBLY:GO_DNA_PACKAGING:GO_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC,
METFORMIN,Mitochondrial complex I (NADH dehydrogenase) inhibitor:Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,"GPD2,NDUFA13",1,0.9333333333333333,"1558,1807,2409,2588,2695,3206,3276,3484,685,865,881,890,902,907,95","1558,1807,2409,2588,2695,3206,3276,3484,685,865,881,890,902,907,95",NA,"78,81,152","78,152",NA,O: 15 U: 0 A: 15,O: 2 U: 0 A: 3,,,Regulon_Gene,2,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR:INHIBITOR,Small molecule,Enzyme,,,CHEMBL1431,"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.:The citric acid (TCA) cycle and respiratory electron transport:Respiratory electron transport:Mitochondrial translation initiation:Mitochondrial translation elongation",GO_OXIDATIVE_PHOSPHORYLATION:GO_RESPIRATORY_ELECTRON_TRANSPORT_CHAIN:GO_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT:GO_ELECTRON_TRANSPORT_CHAIN:GO_CELLULAR_RESPIRATION,HALLMARK_OXIDATIVE_PHOSPHORYLATION:HALLMARK_MYC_TARGETS_V1:HALLMARK_DNA_REPAIR:HALLMARK_MTORC1_SIGNALING
TIPIFARNIB,Protein farnesyltransferase inhibitor,"FNTA,FNTB",0.8666666666666667,1,"1012,1362,1522,1553,175,1804,2188,2208,2233,2241,2279,2325,437,602,890","1012,1362,1522,1553,175,1804,2208,2233,2279,2325,437,602,890",NA,"0,13,90,152","0,13,90,152",NA,O: 13 U: 0 A: 15,O: 4 U: 0 A: 4,,,Regulon_Gene,2,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL289228,"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.:Respiratory electron transport:The citric acid (TCA) cycle and respiratory electron transport:Mitochondrial translation initiation:Mitochondrial translation elongation",GO_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT:GO_OXIDATIVE_PHOSPHORYLATION:GO_RESPIRATORY_ELECTRON_TRANSPORT_CHAIN:GO_CELLULAR_RESPIRATION:GO_MITOCHONDRIAL_TRANSLATIONAL_TERMINATION,HALLMARK_OXIDATIVE_PHOSPHORYLATION
PONEZUMAB,Beta amyloid A4 protein binding agent,APP,1,0.975609756097561,"1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78","1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78",NA,"10,43,47","10,43",NA,O: 41 U: 0 A: 41,O: 2 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT,Antibody,Membrane receptor,,,CHEMBL1743058,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
GSK933776,Beta amyloid A4 protein binding agent,APP,1,0.975609756097561,"1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78","1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78",NA,"10,43,47","10,43",NA,O: 41 U: 0 A: 41,O: 2 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT,Antibody,Membrane receptor,,,CHEMBL2109300,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
BAPINEUZUMAB,Beta amyloid A4 protein binding agent,APP,1,0.975609756097561,"1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78","1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78",NA,"10,43,47","10,43",NA,O: 41 U: 0 A: 41,O: 2 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT,Antibody,Membrane receptor,,,CHEMBL2108576,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
GANTENERUMAB,Beta amyloid A4 protein binding agent,APP,1,0.975609756097561,"1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78","1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78",NA,"10,43,47","10,43",NA,O: 41 U: 0 A: 41,O: 2 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT,Antibody,Membrane receptor,,,CHEMBL1743025,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
SOLANEZUMAB,Beta amyloid A4 protein binding agent,APP,1,0.975609756097561,"1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78","1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78",NA,"10,43,47","10,43",NA,O: 41 U: 0 A: 41,O: 2 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT,Antibody,Membrane receptor,,,CHEMBL1743072,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
ADUCANUMAB,Beta amyloid A4 protein binding agent,APP,1,0.975609756097561,"1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78","1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78",NA,"10,43,47","10,43",NA,O: 41 U: 0 A: 41,O: 2 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT,Antibody,Membrane receptor,,,CHEMBL3039540,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
LECANEMAB,Beta amyloid A4 protein inhibitor,APP,1,0.975609756097561,"1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78","1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78",NA,"10,43,47","10,43",NA,O: 41 U: 0 A: 41,O: 2 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Antibody,Membrane receptor,,,CHEMBL3833321,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
CRENEZUMAB,Beta amyloid A4 protein inhibitor,APP,1,0.975609756097561,"1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78","1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78",NA,"10,43,47","10,43",NA,O: 41 U: 0 A: 41,O: 2 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Antibody,Membrane receptor,,,CHEMBL1743004,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
METFORMIN HYDROCHLORIDE,Mitochondrial complex I (NADH dehydrogenase) inhibitor:Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,"GPD2,NDUFA13",1,0.9333333333333333,"1558,1807,2409,2588,2695,3206,3276,3484,685,865,881,890,902,907,95","1558,1807,2409,2588,2695,3206,3276,3484,685,865,881,890,902,907,95",NA,"78,81,152","78,152",NA,O: 15 U: 0 A: 15,O: 2 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR:INHIBITOR,Small molecule,Enzyme,Vascular toxicity:Metabolism toxicity:Cardiotoxicity:Respiratory toxicity,10047065.0:10027433.0:10007541.0:10038738.0,CHEMBL1703,"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.:The citric acid (TCA) cycle and respiratory electron transport:Respiratory electron transport:Mitochondrial translation initiation:Mitochondrial translation elongation",GO_OXIDATIVE_PHOSPHORYLATION:GO_RESPIRATORY_ELECTRON_TRANSPORT_CHAIN:GO_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT:GO_ELECTRON_TRANSPORT_CHAIN:GO_CELLULAR_RESPIRATION,HALLMARK_OXIDATIVE_PHOSPHORYLATION:HALLMARK_MYC_TARGETS_V1:HALLMARK_DNA_REPAIR:HALLMARK_MTORC1_SIGNALING
OXIGLUTATIONE,Glutathione reductase,GSR,1,1,"1663,2320,2679,41,644,681,707","1663,2320,2679,41,644,681,707",NA,101,101,NA,O: 7 U: 0 A: 7,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,OTHER,Small molecule,Enzyme,,,CHEMBL1372,NA:NA:NA:NA:NA,GO_STRESS_GRANULE_ASSEMBLY:GO_REGULATION_OF_CIRCADIAN_RHYTHM:NA:NA:NA,
ELIGLUSTAT,Ceramide glucosyltransferase inhibitor,UGCG,1,0.9803921568627451,"1144,126,1399,1412,1534,1775,1796,1835,186,1968,1998,2025,2050,2081,2122,2152,2226,2238,2247,2293,2421,2466,2484,2522,2564,2611,2687,2709,2742,2792,2855,2975,3163,3189,3205,3293,3386,3395,3434,3664,3713,3718,449,499,56,584,691,723,760,773,78","1144,126,1399,1412,1534,1775,1796,1835,186,1968,1998,2025,2050,2081,2122,2152,2226,2238,2247,2293,2421,2466,2484,2522,2564,2611,2687,2709,2742,2792,2855,2975,3163,3189,3205,3293,3386,3395,3434,3664,3713,3718,449,499,56,584,691,723,760,773,78",NA,"10,43,47","10,43",NA,O: 51 U: 0 A: 51,O: 2 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL2110588,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
MIGLUSTAT,Ceramide glucosyltransferase inhibitor,UGCG,1,0.9803921568627451,"1144,126,1399,1412,1534,1775,1796,1835,186,1968,1998,2025,2050,2081,2122,2152,2226,2238,2247,2293,2421,2466,2484,2522,2564,2611,2687,2709,2742,2792,2855,2975,3163,3189,3205,3293,3386,3395,3434,3664,3713,3718,449,499,56,584,691,723,760,773,78","1144,126,1399,1412,1534,1775,1796,1835,186,1968,1998,2025,2050,2081,2122,2152,2226,2238,2247,2293,2421,2466,2484,2522,2564,2611,2687,2709,2742,2792,2855,2975,3163,3189,3205,3293,3386,3395,3434,3664,3713,3718,449,499,56,584,691,723,760,773,78",NA,"10,43,47","10,43",NA,O: 51 U: 0 A: 51,O: 2 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL1029,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
ELIGLUSTAT TARTRATE,Ceramide glucosyltransferase inhibitor,UGCG,1,0.9803921568627451,"1144,126,1399,1412,1534,1775,1796,1835,186,1968,1998,2025,2050,2081,2122,2152,2226,2238,2247,2293,2421,2466,2484,2522,2564,2611,2687,2709,2742,2792,2855,2975,3163,3189,3205,3293,3386,3395,3434,3664,3713,3718,449,499,56,584,691,723,760,773,78","1144,126,1399,1412,1534,1775,1796,1835,186,1968,1998,2025,2050,2081,2122,2152,2226,2238,2247,2293,2421,2466,2484,2522,2564,2611,2687,2709,2742,2792,2855,2975,3163,3189,3205,3293,3386,3395,3434,3664,3713,3718,449,499,56,584,691,723,760,773,78",NA,"10,43,47","10,43",NA,O: 51 U: 0 A: 51,O: 2 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL4297066,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
FLUMATINIB,Tyrosine-protein kinase ABL inhibitor,ABL1,1,1,"1011,1034,1092,1152,1180","1011,1034,1092,1152,1180",NA,65,65,NA,O: 5 U: 0 A: 5,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL3545413,Chromatin modifying enzymes:Chromatin organization:RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known:Transcriptional regulation by RUNX1:Transcriptional Regulation by TP53,GO_CHROMATIN_DISASSEMBLY:GO_PROTEIN_DNA_COMPLEX_DISASSEMBLY:GO_COVALENT_CHROMATIN_MODIFICATION:GO_CHROMATIN_REMODELING:GO_PEPTIDYL_LYSINE_MODIFICATION,HALLMARK_MITOTIC_SPINDLE:HALLMARK_G2M_CHECKPOINT
NILOTINIB HYDROCHLORIDE MONOHYDRATE,Tyrosine-protein kinase ABL inhibitor,ABL1,1,1,"1011,1034,1092,1152,1180","1011,1034,1092,1152,1180",NA,65,65,NA,O: 5 U: 0 A: 5,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL1201740,Chromatin modifying enzymes:Chromatin organization:RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known:Transcriptional regulation by RUNX1:Transcriptional Regulation by TP53,GO_CHROMATIN_DISASSEMBLY:GO_PROTEIN_DNA_COMPLEX_DISASSEMBLY:GO_COVALENT_CHROMATIN_MODIFICATION:GO_CHROMATIN_REMODELING:GO_PEPTIDYL_LYSINE_MODIFICATION,HALLMARK_MITOTIC_SPINDLE:HALLMARK_G2M_CHECKPOINT
REBASTINIB,Tyrosine-protein kinase ABL inhibitor,ABL1,1,1,"1011,1034,1092,1152,1180","1011,1034,1092,1152,1180",NA,65,65,NA,O: 5 U: 0 A: 5,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL1738757,Chromatin modifying enzymes:Chromatin organization:RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known:Transcriptional regulation by RUNX1:Transcriptional Regulation by TP53,GO_CHROMATIN_DISASSEMBLY:GO_PROTEIN_DNA_COMPLEX_DISASSEMBLY:GO_COVALENT_CHROMATIN_MODIFICATION:GO_CHROMATIN_REMODELING:GO_PEPTIDYL_LYSINE_MODIFICATION,HALLMARK_MITOTIC_SPINDLE:HALLMARK_G2M_CHECKPOINT
NILOTINIB,Tyrosine-protein kinase ABL inhibitor,ABL1,1,1,"1011,1034,1092,1152,1180","1011,1034,1092,1152,1180",NA,65,65,NA,O: 5 U: 0 A: 5,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,Cardiotoxicity,10007541,CHEMBL255863,Chromatin modifying enzymes:Chromatin organization:RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known:Transcriptional regulation by RUNX1:Transcriptional Regulation by TP53,GO_CHROMATIN_DISASSEMBLY:GO_PROTEIN_DNA_COMPLEX_DISASSEMBLY:GO_COVALENT_CHROMATIN_MODIFICATION:GO_CHROMATIN_REMODELING:GO_PEPTIDYL_LYSINE_MODIFICATION,HALLMARK_MITOTIC_SPINDLE:HALLMARK_G2M_CHECKPOINT
ASCIMINIB,Tyrosine-protein kinase ABL inhibitor,ABL1,1,1,"1011,1034,1092,1152,1180","1011,1034,1092,1152,1180",NA,65,65,NA,O: 5 U: 0 A: 5,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL4208229,Chromatin modifying enzymes:Chromatin organization:RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known:Transcriptional regulation by RUNX1:Transcriptional Regulation by TP53,GO_CHROMATIN_DISASSEMBLY:GO_PROTEIN_DNA_COMPLEX_DISASSEMBLY:GO_COVALENT_CHROMATIN_MODIFICATION:GO_CHROMATIN_REMODELING:GO_PEPTIDYL_LYSINE_MODIFICATION,HALLMARK_MITOTIC_SPINDLE:HALLMARK_G2M_CHECKPOINT
ME-344,Mitochondrial complex I (NADH dehydrogenase) inhibitor,NDUFA13,1,1,"865,881,890,902,907","865,881,890,902,907",NA,152,152,NA,O: 5 U: 0 A: 5,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL3545320,"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.:The citric acid (TCA) cycle and respiratory electron transport:Respiratory electron transport:Complex I biogenesis:Mitochondrial translation initiation",GO_OXIDATIVE_PHOSPHORYLATION:GO_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT:GO_ATP_METABOLIC_PROCESS:GO_RESPIRATORY_ELECTRON_TRANSPORT_CHAIN:GO_ELECTRON_TRANSPORT_CHAIN,HALLMARK_OXIDATIVE_PHOSPHORYLATION:HALLMARK_DNA_REPAIR:HALLMARK_MYC_TARGETS_V1
FGI-101-1A6,Tumor susceptibility gene 101 protein inhibitor,TSG101,1,1,"881,890","881,890",NA,152,152,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Antibody,Unclassified protein,,,CHEMBL2109593,"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.:The citric acid (TCA) cycle and respiratory electron transport:Respiratory electron transport:Complex I biogenesis:Mitochondrial translation initiation",GO_OXIDATIVE_PHOSPHORYLATION:GO_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT:GO_RESPIRATORY_ELECTRON_TRANSPORT_CHAIN:GO_ATP_METABOLIC_PROCESS:GO_ELECTRON_TRANSPORT_CHAIN,HALLMARK_OXIDATIVE_PHOSPHORYLATION:HALLMARK_DNA_REPAIR:HALLMARK_MYC_TARGETS_V1
BB-10901,Neural cell adhesion molecule 1 binding agent,NCAM1,1,1,1100,1100,NA,133,133,NA,O: 1 U: 0 A: 1,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT,Antibody,Adhesion,,,CHEMBL2109484,L1CAM interactions:NCAM signaling for neurite out-growth:NA:NA:NA,GO_CELL_JUNCTION_ASSEMBLY:GO_POSTSYNAPSE_ORGANIZATION:GO_SYNAPSE_ASSEMBLY:GO_DENDRITE_DEVELOPMENT:GO_PROTEIN_POLYMERIZATION,
LORVOTUZUMAB MERTANSINE,Neural cell adhesion molecule 1 binding agent,NCAM1,1,1,1100,1100,NA,133,133,NA,O: 1 U: 0 A: 1,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT,Antibody,Adhesion,,,CHEMBL1743037,L1CAM interactions:NCAM signaling for neurite out-growth:NA:NA:NA,GO_CELL_JUNCTION_ASSEMBLY:GO_POSTSYNAPSE_ORGANIZATION:GO_SYNAPSE_ASSEMBLY:GO_DENDRITE_DEVELOPMENT:GO_PROTEIN_POLYMERIZATION,
VIGABATRIN,Gamma-amino-N-butyrate transaminase inhibitor,ABAT,1,1,"1099,1391,1423,1577,1669,1965,2019,2151,2375,249,2673,3104,3246,334,3469,3692,688","1099,1391,1423,1577,1669,1965,2019,2151,2375,249,2673,3104,3246,334,3469,3692,688",NA,"61,73","61,73",NA,O: 17 U: 0 A: 17,O: 2 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL89598,Neuronal System:Protein-protein interactions at synapses:Neurexins and neuroligins:NA:NA,NA:NA:NA:NA:NA,
GSK2798745,Transient receptor potential cation channel subfamily V member 4 antagonist,TRPV4,1,1,3560,3560,NA,71,71,NA,O: 1 U: 0 A: 1,O: 1 U: 0 A: 1,TRPV4,HSF2,Mutation_Gene,NA,TRUE,FALSE,FALSE,Mutation_Gene,,ANTAGONIST,Small molecule,Ion channel,,,CHEMBL3707225,NA:NA:NA:NA:NA,GO_NEURONAL_STEM_CELL_POPULATION_MAINTENANCE:NA:NA:NA:NA,
GALLIUM NITRATE,Ribonucleoside-diphosphate reductase RR1 inhibitor:Hydroxyapatite sequestering agent,RRM2,0.9230769230769231,0,"1030,1720,1818,2051,2292,2529,3637,366,3676,501,693,906,964","1030,1720,1818,2051,2292,3637,366,3676,501,693,906,964",NA,153,NA,NA,O: 12 U: 0 A: 13,O: 0 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR:SEQUESTERING AGENT,Small molecule,Enzyme,,,CHEMBL1200983,Cellular Senescence:Oxidative Stress Induced Senescence:RNA Polymerase I Promoter Opening:DNA methylation:Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,GO_NUCLEOSOME_ASSEMBLY:GO_NUCLEOSOME_ORGANIZATION:GO_CHROMATIN_ASSEMBLY_OR_DISASSEMBLY:GO_DNA_PACKAGING:GO_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC,
ALEPLASININ,Plasminogen activator inhibitor-1 inhibitor,SERPINE1,0.9107142857142857,0.7857142857142857,"100,1015,1218,1239,1260,1526,157,1595,179,1829,1847,1937,209,2090,2197,2213,223,2282,2303,2327,236,2368,2407,2477,2548,2569,2617,2680,2694,2730,2733,2759,2768,2779,2821,2871,302,3021,3070,3128,3136,3199,3253,3272,3460,3640,39,441,465,483,576,599,680,704,768,789","100,1015,1218,1239,1260,1526,157,179,1829,1847,1937,209,2090,2213,223,2282,2303,2327,2368,2407,2477,2548,2569,2617,2680,2694,2730,2733,2759,2768,2779,2821,2871,302,3021,3070,3128,3199,3253,3272,3460,39,441,465,483,576,599,680,704,768,789",NA,"1,11,17,31","1,11",NA,O: 51 U: 0 A: 56,O: 2 U: 0 A: 4,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Secreted protein,,,CHEMBL325424,Extracellular matrix organization:ECM proteoglycans:Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs):Laminin interactions:MET activates PTK2 signaling,GO_EXTRACELLULAR_STRUCTURE_ORGANIZATION:GO_CELL_SUBSTRATE_ADHESION:GO_CELL_MATRIX_ADHESION:GO_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN:GO_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION:HALLMARK_TNFA_SIGNALING_VIA_NFKB:HALLMARK_COMPLEMENT:HALLMARK_TGF_BETA_SIGNALING:HALLMARK_APOPTOSIS:HALLMARK_PROTEIN_SECRETION:HALLMARK_INFLAMMATORY_RESPONSE:HALLMARK_UV_RESPONSE_DN
F16SIP 131I,Tenascin binding agent,TNC,0.9,1,"1444,1511,2132,2738,2782,3164,42,646,710,752","1444,2132,2738,2782,3164,42,646,710,752",NA,44,44,NA,O: 9 U: 0 A: 10,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT,Antibody,Unclassified protein,,,CHEMBL2109584,Other semaphorin interactions:NA:NA:NA:NA,GO_MULTI_MULTICELLULAR_ORGANISM_PROCESS:GO_NEURON_PROJECTION_EXTENSION_INVOLVED_IN_NEURON_PROJECTION_GUIDANCE:GO_REGULATION_OF_AXON_GUIDANCE:GO_NEPHRON_DEVELOPMENT:GO_UROGENITAL_SYSTEM_DEVELOPMENT,HALLMARK_TNFA_SIGNALING_VIA_NFKB
TENATUMOMAB,Tenascin other,TNC,0.9,1,"1444,1511,2132,2738,2782,3164,42,646,710,752","1444,2132,2738,2782,3164,42,646,710,752",NA,44,44,NA,O: 9 U: 0 A: 10,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,OTHER,Antibody,Unclassified protein,,,CHEMBL1743077,Other semaphorin interactions:NA:NA:NA:NA,GO_MULTI_MULTICELLULAR_ORGANISM_PROCESS:GO_NEURON_PROJECTION_EXTENSION_INVOLVED_IN_NEURON_PROJECTION_GUIDANCE:GO_REGULATION_OF_AXON_GUIDANCE:GO_NEPHRON_DEVELOPMENT:GO_UROGENITAL_SYSTEM_DEVELOPMENT,HALLMARK_TNFA_SIGNALING_VIA_NFKB
81C6 131I,Tenascin binding agent,TNC,0.9,1,"1444,1511,2132,2738,2782,3164,42,646,710,752","1444,2132,2738,2782,3164,42,646,710,752",NA,44,44,NA,O: 9 U: 0 A: 10,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT,Antibody,Unclassified protein,,,CHEMBL2109582,Other semaphorin interactions:NA:NA:NA:NA,GO_MULTI_MULTICELLULAR_ORGANISM_PROCESS:GO_NEURON_PROJECTION_EXTENSION_INVOLVED_IN_NEURON_PROJECTION_GUIDANCE:GO_REGULATION_OF_AXON_GUIDANCE:GO_NEPHRON_DEVELOPMENT:GO_UROGENITAL_SYSTEM_DEVELOPMENT,HALLMARK_TNFA_SIGNALING_VIA_NFKB
F16IL2,Tenascin other,TNC,0.9,1,"1444,1511,2132,2738,2782,3164,42,646,710,752","1444,2132,2738,2782,3164,42,646,710,752",NA,44,44,NA,O: 9 U: 0 A: 10,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,OTHER,Antibody,Unclassified protein,,,CHEMBL2109583,Other semaphorin interactions:NA:NA:NA:NA,GO_MULTI_MULTICELLULAR_ORGANISM_PROCESS:GO_NEURON_PROJECTION_EXTENSION_INVOLVED_IN_NEURON_PROJECTION_GUIDANCE:GO_REGULATION_OF_AXON_GUIDANCE:GO_NEPHRON_DEVELOPMENT:GO_UROGENITAL_SYSTEM_DEVELOPMENT,HALLMARK_TNFA_SIGNALING_VIA_NFKB
MK-8353,MAP kinase ERK1 inhibitor:MAP kinase ERK2 inhibitor,"MAPK1,MAPK3",0.9,0.85,"1164,1194,1507,1531,1633,1672,1694,1776,1903,2018,2047,2218,2417,2705,2803,287,3188,3221,721,756","1164,1194,1507,1531,1633,1672,1694,1776,1903,2018,2047,2417,2705,2803,3188,3221,721,756",NA,"125,126",125,NA,O: 18 U: 0 A: 20,O: 1 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR:INHIBITOR,Small molecule,Enzyme,,,CHEMBL3545001,Signaling by Insulin receptor:Signaling by high-kinase activity BRAF mutants:MAP2K and MAPK activation:Negative regulation of MAPK pathway:Signaling by moderate kinase activity BRAF mutants,GO_ENDOMEMBRANE_SYSTEM_ORGANIZATION:GO_REGULATION_OF_PH:GO_ORGANELLE_INHERITANCE:GO_MONOVALENT_INORGANIC_CATION_HOMEOSTASIS:GO_REGULATION_OF_CELLULAR_PH,
ULIXERTINIB,MAP kinase ERK2 inhibitor:MAP kinase ERK1 inhibitor,"MAPK1,MAPK3",0.9,0.85,"1164,1194,1507,1531,1633,1672,1694,1776,1903,2018,2047,2218,2417,2705,2803,287,3188,3221,721,756","1164,1194,1507,1531,1633,1672,1694,1776,1903,2018,2047,2417,2705,2803,3188,3221,721,756",NA,"125,126",125,NA,O: 18 U: 0 A: 20,O: 1 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR:INHIBITOR,Small molecule,Enzyme,,,CHEMBL3545022,Signaling by Insulin receptor:Signaling by high-kinase activity BRAF mutants:MAP2K and MAPK activation:Negative regulation of MAPK pathway:Signaling by moderate kinase activity BRAF mutants,GO_ENDOMEMBRANE_SYSTEM_ORGANIZATION:GO_REGULATION_OF_PH:GO_ORGANELLE_INHERITANCE:GO_MONOVALENT_INORGANIC_CATION_HOMEOSTASIS:GO_REGULATION_OF_CELLULAR_PH,
RAVOXERTINIB,MAP kinase ERK2 inhibitor:MAP kinase ERK1 inhibitor,"MAPK1,MAPK3",0.9,0.85,"1164,1194,1507,1531,1633,1672,1694,1776,1903,2018,2047,2218,2417,2705,2803,287,3188,3221,721,756","1164,1194,1507,1531,1633,1672,1694,1776,1903,2018,2047,2417,2705,2803,3188,3221,721,756",NA,"125,126",125,NA,O: 18 U: 0 A: 20,O: 1 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR:INHIBITOR,Small molecule,Enzyme,,,CHEMBL3544964,Signaling by Insulin receptor:Signaling by high-kinase activity BRAF mutants:MAP2K and MAPK activation:Negative regulation of MAPK pathway:Signaling by moderate kinase activity BRAF mutants,GO_ENDOMEMBRANE_SYSTEM_ORGANIZATION:GO_REGULATION_OF_PH:GO_ORGANELLE_INHERITANCE:GO_MONOVALENT_INORGANIC_CATION_HOMEOSTASIS:GO_REGULATION_OF_CELLULAR_PH,
LONAFARNIB,Protein farnesyltransferase inhibitor,"FNTA,FNTB",0.8666666666666667,1,"1012,1362,1522,1553,175,1804,2188,2208,2233,2241,2279,2325,437,602,890","1012,1362,1522,1553,175,1804,2208,2233,2279,2325,437,602,890",NA,"0,13,90,152","0,13,90,152",NA,O: 13 U: 0 A: 15,O: 4 U: 0 A: 4,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL298734,"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.:Respiratory electron transport:The citric acid (TCA) cycle and respiratory electron transport:Mitochondrial translation initiation:Mitochondrial translation elongation",GO_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT:GO_OXIDATIVE_PHOSPHORYLATION:GO_RESPIRATORY_ELECTRON_TRANSPORT_CHAIN:GO_CELLULAR_RESPIRATION:GO_MITOCHONDRIAL_TRANSLATIONAL_TERMINATION,HALLMARK_OXIDATIVE_PHOSPHORYLATION
DIGITOXIN,Sodium/potassium-transporting ATPase inhibitor,ATP1A1,0.8533333333333334,0.9333333333333333,"100,1015,105,1050,1093,11,1137,1159,1218,1418,1420,1526,1557,157,1641,1732,1755,1759,179,1829,1847,1898,1987,2040,206,2210,2213,223,2282,2285,2327,2334,236,2407,2617,2630,2680,2684,2700,2730,2759,2768,2821,2871,2903,3021,3070,3128,3161,3199,3253,3272,3460,3467,36,3677,379,381,382,39,441,45,465,483,488,539,559,576,599,680,686,704,718,768,815","100,1015,105,1050,11,1137,1159,1218,1418,1420,1526,1557,157,1641,1732,1755,179,1829,1847,1898,2040,2213,223,2282,2327,2334,2407,2617,2630,2680,2684,2700,2730,2759,2768,2821,2871,3021,3070,3128,3161,3199,3253,3272,3460,3677,379,381,39,441,45,465,483,488,539,559,576,599,680,686,704,718,768,815",NA,"1,8,11,13,14,17,21","1,8,11,13",NA,O: 64 U: 0 A: 75,O: 4 U: 0 A: 7,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL254219,Extracellular matrix organization:ECM proteoglycans:Laminin interactions:MET activates PTK2 signaling:SARS-CoV Infections,GO_CELL_SUBSTRATE_ADHESION:GO_CELL_MATRIX_ADHESION:GO_EXTRACELLULAR_STRUCTURE_ORGANIZATION:GO_POSITIVE_REGULATION_OF_CELL_MATRIX_ADHESION:GO_AMEBOIDAL_TYPE_CELL_MIGRATION,HALLMARK_TNFA_SIGNALING_VIA_NFKB:HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION:HALLMARK_UV_RESPONSE_DN:HALLMARK_TGF_BETA_SIGNALING
DESLANOSIDE,Sodium/potassium-transporting ATPase inhibitor,ATP1A1,0.8533333333333334,0.9333333333333333,"100,1015,105,1050,1093,11,1137,1159,1218,1418,1420,1526,1557,157,1641,1732,1755,1759,179,1829,1847,1898,1987,2040,206,2210,2213,223,2282,2285,2327,2334,236,2407,2617,2630,2680,2684,2700,2730,2759,2768,2821,2871,2903,3021,3070,3128,3161,3199,3253,3272,3460,3467,36,3677,379,381,382,39,441,45,465,483,488,539,559,576,599,680,686,704,718,768,815","100,1015,105,1050,11,1137,1159,1218,1418,1420,1526,1557,157,1641,1732,1755,179,1829,1847,1898,2040,2213,223,2282,2327,2334,2407,2617,2630,2680,2684,2700,2730,2759,2768,2821,2871,3021,3070,3128,3161,3199,3253,3272,3460,3677,379,381,39,441,45,465,483,488,539,559,576,599,680,686,704,718,768,815",NA,"1,8,11,13,14,17,21","1,8,11,13",NA,O: 64 U: 0 A: 75,O: 4 U: 0 A: 7,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL1614,Extracellular matrix organization:ECM proteoglycans:Laminin interactions:MET activates PTK2 signaling:SARS-CoV Infections,GO_CELL_SUBSTRATE_ADHESION:GO_CELL_MATRIX_ADHESION:GO_EXTRACELLULAR_STRUCTURE_ORGANIZATION:GO_POSITIVE_REGULATION_OF_CELL_MATRIX_ADHESION:GO_AMEBOIDAL_TYPE_CELL_MIGRATION,HALLMARK_TNFA_SIGNALING_VIA_NFKB:HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION:HALLMARK_UV_RESPONSE_DN:HALLMARK_TGF_BETA_SIGNALING
DIGOXIN,Sodium/potassium-transporting ATPase inhibitor,ATP1A1,0.8533333333333334,0.9333333333333333,"100,1015,105,1050,1093,11,1137,1159,1218,1418,1420,1526,1557,157,1641,1732,1755,1759,179,1829,1847,1898,1987,2040,206,2210,2213,223,2282,2285,2327,2334,236,2407,2617,2630,2680,2684,2700,2730,2759,2768,2821,2871,2903,3021,3070,3128,3161,3199,3253,3272,3460,3467,36,3677,379,381,382,39,441,45,465,483,488,539,559,576,599,680,686,704,718,768,815","100,1015,105,1050,11,1137,1159,1218,1418,1420,1526,1557,157,1641,1732,1755,179,1829,1847,1898,2040,2213,223,2282,2327,2334,2407,2617,2630,2680,2684,2700,2730,2759,2768,2821,2871,3021,3070,3128,3161,3199,3253,3272,3460,3677,379,381,39,441,45,465,483,488,539,559,576,599,680,686,704,718,768,815",NA,"1,8,11,13,14,17,21","1,8,11,13",NA,O: 64 U: 0 A: 75,O: 4 U: 0 A: 7,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL1751,Extracellular matrix organization:ECM proteoglycans:Laminin interactions:MET activates PTK2 signaling:SARS-CoV Infections,GO_CELL_SUBSTRATE_ADHESION:GO_CELL_MATRIX_ADHESION:GO_EXTRACELLULAR_STRUCTURE_ORGANIZATION:GO_POSITIVE_REGULATION_OF_CELL_MATRIX_ADHESION:GO_AMEBOIDAL_TYPE_CELL_MIGRATION,HALLMARK_TNFA_SIGNALING_VIA_NFKB:HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION:HALLMARK_UV_RESPONSE_DN:HALLMARK_TGF_BETA_SIGNALING
ACETYLDIGITOXIN,Sodium/potassium-transporting ATPase inhibitor,ATP1A1,0.8533333333333334,0.9333333333333333,"100,1015,105,1050,1093,11,1137,1159,1218,1418,1420,1526,1557,157,1641,1732,1755,1759,179,1829,1847,1898,1987,2040,206,2210,2213,223,2282,2285,2327,2334,236,2407,2617,2630,2680,2684,2700,2730,2759,2768,2821,2871,2903,3021,3070,3128,3161,3199,3253,3272,3460,3467,36,3677,379,381,382,39,441,45,465,483,488,539,559,576,599,680,686,704,718,768,815","100,1015,105,1050,11,1137,1159,1218,1418,1420,1526,1557,157,1641,1732,1755,179,1829,1847,1898,2040,2213,223,2282,2327,2334,2407,2617,2630,2680,2684,2700,2730,2759,2768,2821,2871,3021,3070,3128,3161,3199,3253,3272,3460,3677,379,381,39,441,45,465,483,488,539,559,576,599,680,686,704,718,768,815",NA,"1,8,11,13,14,17,21","1,8,11,13",NA,O: 64 U: 0 A: 75,O: 4 U: 0 A: 7,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL3545057,Extracellular matrix organization:ECM proteoglycans:Laminin interactions:MET activates PTK2 signaling:SARS-CoV Infections,GO_CELL_SUBSTRATE_ADHESION:GO_CELL_MATRIX_ADHESION:GO_EXTRACELLULAR_STRUCTURE_ORGANIZATION:GO_POSITIVE_REGULATION_OF_CELL_MATRIX_ADHESION:GO_AMEBOIDAL_TYPE_CELL_MIGRATION,HALLMARK_TNFA_SIGNALING_VIA_NFKB:HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION:HALLMARK_UV_RESPONSE_DN:HALLMARK_TGF_BETA_SIGNALING
BMS-911543,Tyrosine-protein kinase JAK2 inhibitor,JAK2,0.85,1,"1012,1157,1362,1522,175,1804,2006,2208,2233,2241,2270,2325,2350,2370,2383,2404,291,437,506,602","1012,1157,1362,1522,175,1804,2006,2208,2233,2325,2370,2383,2404,291,437,506,602",NA,"0,90","0,90",NA,O: 17 U: 0 A: 20,O: 2 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL3545215,Neutrophil degranulation:Diseases of programmed cell death:NA:NA:NA,GO_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY:GO_GLYCOLIPID_CATABOLIC_PROCESS:GO_CERAMIDE_CATABOLIC_PROCESS:GO_PROTEIN_POLYMERIZATION:GO_GLYCOSPHINGOLIPID_METABOLIC_PROCESS,
NS-018,Tyrosine-protein kinase JAK2 inhibitor,JAK2,0.85,1,"1012,1157,1362,1522,175,1804,2006,2208,2233,2241,2270,2325,2350,2370,2383,2404,291,437,506,602","1012,1157,1362,1522,175,1804,2006,2208,2233,2325,2370,2383,2404,291,437,506,602",NA,"0,90","0,90",NA,O: 17 U: 0 A: 20,O: 2 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL3545217,Neutrophil degranulation:Diseases of programmed cell death:NA:NA:NA,GO_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY:GO_GLYCOLIPID_CATABOLIC_PROCESS:GO_CERAMIDE_CATABOLIC_PROCESS:GO_PROTEIN_POLYMERIZATION:GO_GLYCOSPHINGOLIPID_METABOLIC_PROCESS,
AC-430,Tyrosine-protein kinase JAK2 inhibitor,JAK2,0.85,1,"1012,1157,1362,1522,175,1804,2006,2208,2233,2241,2270,2325,2350,2370,2383,2404,291,437,506,602","1012,1157,1362,1522,175,1804,2006,2208,2233,2325,2370,2383,2404,291,437,506,602",NA,"0,90","0,90",NA,O: 17 U: 0 A: 20,O: 2 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL3545241,Neutrophil degranulation:Diseases of programmed cell death:NA:NA:NA,GO_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY:GO_GLYCOLIPID_CATABOLIC_PROCESS:GO_CERAMIDE_CATABOLIC_PROCESS:GO_PROTEIN_POLYMERIZATION:GO_GLYCOSPHINGOLIPID_METABOLIC_PROCESS,
GANDOTINIB,Tyrosine-protein kinase JAK2 inhibitor,JAK2,0.85,1,"1012,1157,1362,1522,175,1804,2006,2208,2233,2241,2270,2325,2350,2370,2383,2404,291,437,506,602","1012,1157,1362,1522,175,1804,2006,2208,2233,2325,2370,2383,2404,291,437,506,602",NA,"0,90","0,90",NA,O: 17 U: 0 A: 20,O: 2 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL2107823,Neutrophil degranulation:Diseases of programmed cell death:NA:NA:NA,GO_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY:GO_GLYCOLIPID_CATABOLIC_PROCESS:GO_CERAMIDE_CATABOLIC_PROCESS:GO_PROTEIN_POLYMERIZATION:GO_GLYCOSPHINGOLIPID_METABOLIC_PROCESS,
AZD-1480,Tyrosine-protein kinase JAK2 inhibitor,JAK2,0.85,1,"1012,1157,1362,1522,175,1804,2006,2208,2233,2241,2270,2325,2350,2370,2383,2404,291,437,506,602","1012,1157,1362,1522,175,1804,2006,2208,2233,2325,2370,2383,2404,291,437,506,602",NA,"0,90","0,90",NA,O: 17 U: 0 A: 20,O: 2 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL1231124,Neutrophil degranulation:Diseases of programmed cell death:NA:NA:NA,GO_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY:GO_GLYCOLIPID_CATABOLIC_PROCESS:GO_CERAMIDE_CATABOLIC_PROCESS:GO_PROTEIN_POLYMERIZATION:GO_GLYCOSPHINGOLIPID_METABOLIC_PROCESS,
XL-019,Tyrosine-protein kinase JAK2 inhibitor,JAK2,0.85,1,"1012,1157,1362,1522,175,1804,2006,2208,2233,2241,2270,2325,2350,2370,2383,2404,291,437,506,602","1012,1157,1362,1522,175,1804,2006,2208,2233,2325,2370,2383,2404,291,437,506,602",NA,"0,90","0,90",NA,O: 17 U: 0 A: 20,O: 2 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL3545328,Neutrophil degranulation:Diseases of programmed cell death:NA:NA:NA,GO_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY:GO_GLYCOLIPID_CATABOLIC_PROCESS:GO_CERAMIDE_CATABOLIC_PROCESS:GO_PROTEIN_POLYMERIZATION:GO_GLYCOSPHINGOLIPID_METABOLIC_PROCESS,
FORIGERIMOD,Heat shock cognate 71 kDa protein inhibitor,HSPA8,0.8333333333333334,1,"1012,1157,1196,1522,1553,1606,1804,2006,215,2183,2198,2208,2233,2240,2241,2265,2279,2304,2325,2370,2393,2404,2704,291,3634,3679,437,461,602,637","1012,1157,1196,1522,1553,1606,1804,2006,215,2183,2198,2208,2233,2279,2325,2370,2404,2704,291,3634,3679,437,461,602,637",NA,"13,90,128","13,90,128",NA,O: 25 U: 0 A: 30,O: 3 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Protein,Other cytosolic protein,,,CHEMBL3989409,NA:NA:NA:NA:NA,GO_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY:GO_GLYCOLIPID_CATABOLIC_PROCESS:GO_CERAMIDE_CATABOLIC_PROCESS:GO_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION:GO_REGULATION_OF_PLATELET_ACTIVATION,
FORIGERIMOD ACETATE,Heat shock cognate 71 kDa protein inhibitor,HSPA8,0.8333333333333334,1,"1012,1157,1196,1522,1553,1606,1804,2006,215,2183,2198,2208,2233,2240,2241,2265,2279,2304,2325,2370,2393,2404,2704,291,3634,3679,437,461,602,637","1012,1157,1196,1522,1553,1606,1804,2006,215,2183,2198,2208,2233,2279,2325,2370,2404,2704,291,3634,3679,437,461,602,637",NA,"13,90,128","13,90,128",NA,O: 25 U: 0 A: 30,O: 3 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Protein,Other cytosolic protein,,,CHEMBL3989801,NA:NA:NA:NA:NA,GO_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY:GO_GLYCOLIPID_CATABOLIC_PROCESS:GO_CERAMIDE_CATABOLIC_PROCESS:GO_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION:GO_REGULATION_OF_PLATELET_ACTIVATION,
TOFERSEN,SOD1 mRNA inhibitor,SOD1,0.8333333333333334,1,"1252,1661,1828,2008,3069,552","1661,1828,2008,3069,552",NA,"128,137","128,137",NA,O: 5 U: 0 A: 6,O: 2 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Oligonucleotide,Enzyme,,,CHEMBL3833346,NA:NA:NA:NA:NA,GO_CELLULAR_IRON_ION_HOMEOSTASIS:GO_IRON_ION_HOMEOSTASIS:GO_CELLULAR_TRANSITION_METAL_ION_HOMEOSTASIS:GO_TRANSITION_METAL_ION_HOMEOSTASIS:GO_CELLULAR_RESPONSE_TO_NITROGEN_STARVATION,HALLMARK_OXIDATIVE_PHOSPHORYLATION:HALLMARK_ADIPOGENESIS
BIMAGRUMAB,Activin receptor type-2B antagonist,ACVR2B,0.8333333333333334,0.8333333333333334,"1011,1092,1112,1152,1568,987","1011,1092,1112,1152,987",NA,"65,66",65,NA,O: 5 U: 0 A: 6,O: 1 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,ANTAGONIST,Antibody,Enzyme,,,CHEMBL3137353,Chromatin modifying enzymes:Chromatin organization:RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known:Transcriptional regulation by RUNX1:Transcriptional Regulation by TP53,GO_COVALENT_CHROMATIN_MODIFICATION:GO_CHROMATIN_DISASSEMBLY:GO_PROTEIN_DNA_COMPLEX_DISASSEMBLY:GO_PEPTIDYL_LYSINE_MODIFICATION:GO_CHROMATIN_REMODELING,HALLMARK_MITOTIC_SPINDLE:HALLMARK_G2M_CHECKPOINT
PEGAPTANIB SODIUM,Vascular endothelial growth factor A antagonist,VEGFA,0.8260869565217391,1,"1074,1119,1221,1226,1330,1339,1444,1709,1774,2060,2738,2782,2946,2956,3089,3220,3424,42,491,543,646,752,818","1074,1119,1221,1226,1330,1444,1709,2060,2738,2782,2956,3089,3220,42,491,543,646,752,818",NA,"35,44,169","35,44,169",NA,O: 19 U: 0 A: 23,O: 3 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,ANTAGONIST,Unknown,Secreted protein,,,CHEMBL1201421,"Metabolism of carbohydrates:Glycogen synthesis:Plasma lipoprotein assembly, remodeling, and clearance:Other semaphorin interactions:NA",GO_MULTI_MULTICELLULAR_ORGANISM_PROCESS:GO_RESPONSE_TO_OXYGEN_LEVELS:GO_UROGENITAL_SYSTEM_DEVELOPMENT:GO_NEPHRON_DEVELOPMENT:GO_NEURON_PROJECTION_GUIDANCE,HALLMARK_HYPOXIA:HALLMARK_MTORC1_SIGNALING:HALLMARK_TNFA_SIGNALING_VIA_NFKB
RANIBIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,0.8260869565217391,1,"1074,1119,1221,1226,1330,1339,1444,1709,1774,2060,2738,2782,2946,2956,3089,3220,3424,42,491,543,646,752,818","1074,1119,1221,1226,1330,1444,1709,2060,2738,2782,2956,3089,3220,42,491,543,646,752,818",NA,"35,44,169","35,44,169",NA,O: 19 U: 0 A: 23,O: 3 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Antibody,Secreted protein,,,CHEMBL1201825,"Metabolism of carbohydrates:Glycogen synthesis:Plasma lipoprotein assembly, remodeling, and clearance:Other semaphorin interactions:NA",GO_MULTI_MULTICELLULAR_ORGANISM_PROCESS:GO_RESPONSE_TO_OXYGEN_LEVELS:GO_UROGENITAL_SYSTEM_DEVELOPMENT:GO_NEPHRON_DEVELOPMENT:GO_NEURON_PROJECTION_GUIDANCE,HALLMARK_HYPOXIA:HALLMARK_MTORC1_SIGNALING:HALLMARK_TNFA_SIGNALING_VIA_NFKB
BROLUCIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,0.8260869565217391,1,"1074,1119,1221,1226,1330,1339,1444,1709,1774,2060,2738,2782,2946,2956,3089,3220,3424,42,491,543,646,752,818","1074,1119,1221,1226,1330,1444,1709,2060,2738,2782,2956,3089,3220,42,491,543,646,752,818",NA,"35,44,169","35,44,169",NA,O: 19 U: 0 A: 23,O: 3 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Antibody,Secreted protein,,,CHEMBL3707357,"Metabolism of carbohydrates:Glycogen synthesis:Plasma lipoprotein assembly, remodeling, and clearance:Other semaphorin interactions:NA",GO_MULTI_MULTICELLULAR_ORGANISM_PROCESS:GO_RESPONSE_TO_OXYGEN_LEVELS:GO_UROGENITAL_SYSTEM_DEVELOPMENT:GO_NEPHRON_DEVELOPMENT:GO_NEURON_PROJECTION_GUIDANCE,HALLMARK_HYPOXIA:HALLMARK_MTORC1_SIGNALING:HALLMARK_TNFA_SIGNALING_VIA_NFKB
TAGRAXOFUSP,Interleukin-3 receptor subunit alpha binding agent:Elongation factor 2 inhibitor,EEF2,0.8181818181818182,0.8181818181818182,"1315,2178,2881,3359,3456,3586,3643,386,667,922,929","1315,2178,2881,3359,3456,3586,3643,386,667",NA,"50,52,152,157","50,52,152",NA,O: 9 U: 0 A: 11,O: 3 U: 0 A: 4,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT:INHIBITOR,Protein,Membrane receptor:Other cytosolic protein,Nephrotoxicity,10038359,CHEMBL4297573,NA:NA:NA:NA:NA,GO_POST_EMBRYONIC_ANIMAL_MORPHOGENESIS:GO_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS:GO_AGING:GO_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE:GO_RESPONSE_TO_SALT_STRESS,
